Scott D Bembenek

Determination of a Focused Mini Kinase Panel for Early Identification of Selective Kinase Inhibitors

Scott D Bembenek, Gavin Hirst, Taraneh Mirzadegan, 2018, J. Chem. Inf. Model..

A Web-based chemoinformatics system for drug discovery.

Brett A Tounge, Scott D Bembenek, Steven J Coats, 2004, Methods in molecular biology.

Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements.

James P Edwards, Scott D Bembenek, Lars Karlsson, 2009, Bioorganic & medicinal chemistry letters.

Ligand efficiency and fragment-based drug discovery.

Brett A Tounge, Charles H Reynolds, Scott D Bembenek, 2009, Drug discovery today.

Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.

Scott D Bembenek, Sándor Szalma, S. Bembenek, 2006, Journal of molecular graphics & modelling.

The role of molecular size in ligand efficiency.

Brett A Tounge, Charles H Reynolds, Scott D Bembenek, 2007, Bioorganic & medicinal chemistry letters.

Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors.

James P Edwards, Scott D Bembenek, Lars Karlsson, 2010, Bioorganic & medicinal chemistry letters.